PI3K Pathway Activation Provides a Novel Therapeutic Target for Pediatric Ependymoma and Is an Independent Marker of Progression-Free Survival
Rogers, H. A., Mayne, C., Chapman, R. J., Kilday, J.-P., Coyle, B., Grundy, R. G.Volume:
19
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-13-0222
Date:
December, 2013
File:
PDF, 1.93 MB
english, 2013